Hemoglobin
Biomarker8 papers2 findings
- Humans6
Interventions
1GLP-1 receptor agonists
no changein humans1
1 study
GLP-1 receptor agonists
no changein humans1
GLP-1 receptor agonists have no effect on hemoglobin in humans (mean difference of 0.06 [95% CI, -0.004 to 0.12] g/dL).
“hemoglobin levels remained comparable between groups (10.9 vs 10.84 g/dL, with a mean difference of 0.06 [95% CI, -0.004 to 0.12])”
Humans12 months
Real-world Evidence for Improvements in Inflammation and Anemia Biomarkers After the Initiation of GLP-1RA in Patients Receiving Hemodialysis · Kidney medicine · 17 Jul 2026
Associations
1Mortality
upin humans1
1 study
Mortality
upin humans1
Hemoglobin is associated with mortality in humans.
“In the 1-year models, age, male sex, ASA IV status, dementia or cognitive impairment, and lower preoperative hemoglobin levels were independently associated with mortality.”
Humansafter hip fracture surgery1 year
Aggregation-Sensitive Mortality Associations and Firth Penalized Logistic Regression After Hip Fracture Surgery: A Retrospective Cohort Study · Journal of clinical medicine · 16 Sep 2026
Latest
26High hemoglobin glycation index is linked to stroke risk
In middle-aged and older adults, high hemoglobin glycation index was associated with incident stroke (adjusted hazard ratio 1.392), persisting after…In middle-aged and older adults, high hemoglobin glycation index was associated with incident stroke (adjusted hazard ratio 1.392), persisting after HbA1c adjustment (hazard ratio 1.333).
High HbA1c-to-HDL-C ratio linked to CVD risk in older adults
Older adults in the highest ratio quartile had a higher risk of incident cardiovascular disease than those in the lowest (HR = 2.111) over five years.Older adults in the highest ratio quartile had a higher risk of incident cardiovascular disease than those in the lowest (HR = 2.111) over five years.
Sarcopenia with metabolic syndrome links to cognitive decline
Their co-occurrence showed a 2.64-fold higher odds of persistently low cognition and 2.38-fold higher odds of rapid decline in 5,985 older adults.Their co-occurrence showed a 2.64-fold higher odds of persistently low cognition and 2.38-fold higher odds of rapid decline in 5,985 older adults.
Survodutide reduces weight in adults with diabetes and obesity
Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.